Terms: = Germ cell tumor AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566
132 results:
1. Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study.
Zeng C; Zhang C; He C; Song H
BMC Genomics; 2023 Dec; 24(1):784. PubMed ID: 38110895
[TBL] [Abstract] [Full Text] [Related]
2. Development and external validation of dual online tools for prognostic assessment in elderly patients with high-grade glioma: a comprehensive study using SEER and Chinese cohorts.
Zhang H; Jiang X; Ren F; Gu Q; Yao J; Wang X; Zou S; Gan Y; Gu J; Xu Y; Wang Z; Liu S; Wang X; Wei B
Front Endocrinol (Lausanne); 2023; 14():1307256. PubMed ID: 38075045
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
Lauritsen J; Sauvé N; Tryakin A; Jiang DM; Huddart R; Heng DYC; Terbuch A; Winquist E; Chovanec M; Hentrich M; Fankhauser CD; Shamash J; Del Muro XG; Vaughn D; Heidenreich A; Sternberg CN; Sweeney C; Necchi A; Bokemeyer C; Bandak M; Jandari A; Collette L; Gillessen S; Beyer J; Daugaard G
Br J Cancer; 2023 Nov; 129(11):1759-1765. PubMed ID: 37777577
[TBL] [Abstract] [Full Text] [Related]
4. Identification and verification of potential biomarkers in sertoli cell-only syndrome via bioinformatics analysis.
Jiang Y; Yang X; Li L; Lv X; Wang R; Zhang H; Liu R
Sci Rep; 2023 Jul; 13(1):12164. PubMed ID: 37500704
[TBL] [Abstract] [Full Text] [Related]
5. Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma.
Zeng L; Xu H; Li SH; Xu SY; Chen K; Qin LJ; Miao L; Wang F; Deng L; Wang FH; Li L; Fu S; Liu N; Wang R; Li YQ; Wang HY
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37130627
[TBL] [Abstract] [Full Text] [Related]
6. [
Graef J; Bluemel S; Brenner W; Amthauer H; Truckenmueller P; Kaul D; Vajkoczy P; Onken JS; Furth C
J Nucl Med; 2023 Jun; 64(6):892-895. PubMed ID: 37116918
[TBL] [Abstract] [Full Text] [Related]
7. Longitudinal Analysis of Cancer Risk in Children and Adults With germline PTEN Variants.
Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
[TBL] [Abstract] [Full Text] [Related]
8. Optimizing b-values schemes for diffusion MRI of the brain with segmented Intravoxel Incoherent Motion (IVIM) model.
Paganelli C; Zampini MA; Morelli L; Buizza G; Fontana G; Anemoni L; Imparato S; Riva G; Iannalfi A; Orlandi E; Baroni G
J Appl Clin Med Phys; 2023 Jun; 24(6):e13986. PubMed ID: 37031365
[TBL] [Abstract] [Full Text] [Related]
9. Association between GPC2 polymorphisms and neuroblastoma risk in Chinese children.
Li M; Zhang X; Liu J; Zhou C; Miao L; He J; Wu H; Zhang R
J Clin Lab Anal; 2023 Mar; 37(5):e24866. PubMed ID: 36920409
[TBL] [Abstract] [Full Text] [Related]
10. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract] [Full Text] [Related]
11. C118P exerted potent anti-tumor effects against melanoma with induction of G2/M arrest via inhibiting the expression of bub1b.
Ren K; Zhou M; Li L; Wang C; Yuan S; Li H
J Dermatol Sci; 2022 Nov; 108(2):58-67. PubMed ID: 36424293
[TBL] [Abstract] [Full Text] [Related]
12. Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI.
Kurokawa R; Kurokawa M; Baba A; Kim J; Capizzano A; Bapuraj J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Nov; 101(44):e31708. PubMed ID: 36343086
[TBL] [Abstract] [Full Text] [Related]
13. [Correlation analysis of clock genes and MEN2 medullary thyroid carcinoma].
Mou YK; Ren C; Li YM; Yu GH; Zheng GB; Song H; Lu CX; Tian RX; Song XC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1079-1086. PubMed ID: 36177562
[No Abstract] [Full Text] [Related]
14. Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells.
Denisova OV; Merisaari J; Kaur A; Yetukuri L; Jumppanen M; von Schantz-Fant C; Ohlmeyer M; Wennerberg K; Aittokallio T; Taipale M; Westermarck J
Sci Rep; 2022 Aug; 12(1):13796. PubMed ID: 35963891
[TBL] [Abstract] [Full Text] [Related]
15. Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1325-1332. PubMed ID: 35953276
[TBL] [Abstract] [Full Text] [Related]
16. germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial Cancer.
Chen OJ; Castellsagué E; Moustafa-Kamal M; Nadaf J; Rivera B; Fahiminiya S; Wang Y; Gamache I; Pacifico C; Jiang L; Carrot-Zhang J; Witkowski L; Berghuis AM; Schönberger S; Schneider D; Hillmer M; Bens S; Siebert R; Stewart CJR; Zhang Z; Chao WCH; Greenwood CMT; Barford D; Tischkowitz M; Majewski J; Foulkes WD; Teodoro JG
Cancer Res; 2022 Oct; 82(19):3499-3515. PubMed ID: 35913887
[TBL] [Abstract] [Full Text] [Related]
17. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Lassman AB; Pugh SL; Wang TJC; Aldape K; Gan HK; Preusser M; Vogelbaum MA; Sulman EP; Won M; Zhang P; Moazami G; Macsai MS; Gilbert MR; Bain EE; Blot V; Ansell PJ; Samanta S; Kundu MG; Armstrong TS; Wefel JS; Seidel C; de Vos FY; Hsu S; Cardona AF; Lombardi G; Bentsion D; Peterson RA; Gedye C; Bourg V; Wick A; Curran WJ; Mehta MP
Neuro Oncol; 2023 Feb; 25(2):339-350. PubMed ID: 35849035
[TBL] [Abstract] [Full Text] [Related]
18. Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis.
Surov A; Meyer HJ; Wienke A
Oncology; 2022; 100(9):498-504. PubMed ID: 35817000
[No Abstract] [Full Text] [Related]
19. Glioma Subtypes Based on the Activity Changes of Immunologic and Hallmark Gene Sets in Cancer.
Chen S
Front Endocrinol (Lausanne); 2022; 13():879233. PubMed ID: 35774141
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.
Kennedy OJ; Kicinski M; Valpione S; Gandini S; Suciu S; Blank CU; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; van Akkooi ACJ; Robert C; Eggermont AMM; Lorigan P; Mandala M
Eur J Cancer; 2022 Apr; 165():97-112. PubMed ID: 35220182
[TBL] [Abstract] [Full Text] [Related]
[Next]
